Some observations on the treatment of porphyrias with CaEDTA.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001831:Body Temperature; D002118:Calcium / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D002712:Chlorides / Q000097:blood; D004231:Diuresis; D004492:Edetic Acid / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D011164:Porphyrias / Q000145:classification / Q000188:drug therapy*; D011166:Porphyrins / Q000652:urine; D012964:Sodium / Q000097:blood; D014882:Water-Electrolyte Balance; D015032:Zinc / Q000652:urine*
D002712:Chlorides; D011166:Porphyrins; D004492:Edetic Acid; D012964:Sodium; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D015032:Zinc; D002118:Calcium